To read more on this topic click here.
World-first Parkinson’s stem cells trial
Author: Simge Eva DoganPublished: 9 August 2018
Prep: Cook: Serves:
Scientists at a Japanese university will carry out a world-first clinical trial transplanting reprogrammed stem cells into the brains of seven people with Parkinson’s.
Researchers believe the process – which was tested on monkeys last year – will allow the brain to create dopamine to counter the effects of Parkinson’s.
Shinya Yamanaka, who is working on the study and won the Nobel Prize in 2012 for his work with stem cells, said: “We intend to carry on conducting our research carefully, yet expeditiously, in coordination with Kyoto University Hospital, so that new treatment will be brought to patients as soon as possible.”
Researchers are hoping to create a treatment that will be covered by national health insurance in Japan.
For more information on the latest Parkinson’s research please visit the EPDA website.
Share this story
EU approval for Medtronic DBS systems improves access to full-body MRI scans
Patients receiving DBS therapy have the option of full-body MRI scansREAD MORE
Fighting Fit: tackling Parkinson’s in the workplace
We talk to the founders of a new programme in Buckinghamshire, UKREAD MORE
Apple Watch to detect Parkinson’s symptoms
The tech giant announced the news at a recent technology eventREAD MORE